Introduction
As clinicians, we strive to use antibiotics selectively as there is increasing awareness of the importance of antibiotic stewardship and the risk associated with antibiotic overuse. In this clinical consensus document, the American Association for the Surgery of Trauma (AAST) Critical Care Committee aims to provide practical guidance to the surgical intensivist on the best practices in the assessment and prophylaxis of adult trauma patients, ≥16 years of age, at risk for infection due to their injuries sustained. These recommendations are summarized in tables 1 and 2.
Table 1.
Type of contamination | Antibiotic recommendations | Additional considerations |
Water contamination | Short course, 3–5 days Salt water
Freshwater
|
|
Soil contamination | Short course, 3–5 days
|
|
Mammalian bites (human, dog, or cat) | Short course, 3–5 days
|
Table 2.
Injury | Antibiotic recommendations | Additional considerations |
Face and scalp | ||
Open or contaminated facial fractures | Prophylactic antibiotics 24 h or less
|
|
Closed or non-contaminated operative facial fractures | Preoperative antibiotics
No postoperative antibiotics |
|
Non-operative facial fractures | No prophylactic antibiotics |
|
Facial and scalp lacerations | Prophylactic antibiotics 24 h or less if complex or high-risk patient
|
|
Nasal packing | No prophylactic antibiotics | |
Central nervous system | ||
Pneumocephalus | No prophylactic antibiotics |
|
CSF leaks | No prophylactic antibiotics |
|
Penetrating brain injury | Short course of prophylactic antibiotics, <3 days
|
|
Penetrating spine injury | Short course of prophylactic antibiotics, no more than 48 h
|
|
Extremity | ||
Closed extremity fractures | No prophylactic antibiotics if non-operative management Preoperative antibiotics within 1 h of incision
|
|
Open extremity fractures | Prophylactic antibiotics 24 h or less
|
|
Soft tissue injury | ||
Soft tissue Lacerations/stab wounds | Prophylactic antibiotics 24 h or less if complex or high-risk patient
|
High-risk infection
|
GSW | Prophylactic antibiotics 24 h or less if complex or high-risk patient
|
|
Burn injury | No prophylactic antibiotics |
Providers should take into account their institutional antibiogram when choosing antibiotics for prophylaxis and/or treatment.
CNS, central nervous system; CSF, cerebrospinal fluid; GN, Gram-negative; GP, Gram-positive; GSW, gunshot wound.
Methods
The AAST Critical Care Committee chose antibiotic management in the intensive care unit (ICU) as a clinically relevant topic for review. This document is one of a three-part TSACO series on this topic. The subtopics reviewed are not comprehensive for the topic of antibiotic management in the ICU but were specifically selected to be practical and useful for the surgical intensivist. A working group was formed from the committee at large to complete this work. The members of the working group were each assigned a subtopic to review using research to date. The members were asked to base their recommendations on research within the last 10 years. If research is unique, important, and has not been replicated, then it may be used even if it is older than 10 years. The research on which the recommendations are based was compiled at the discretion of the working group. Iterative selection of studies was not performed as in a systematic review, and the methodology of the literature search was at the discretion of the authors. Any topic with discrepant or minimal supporting literature was reviewed by the AAST Critical Care Committee with an anonymous survey. The recommendations were then reviewed by the AAST Critical Care Committee at large. Consensus was either achieved by conference or reported as ‘no consensus’. The recommendations apply to adult trauma patients, ≥16 years of age. Clinicians must take into account other considerations such as weight and pregnancy for adjustments in dosing and specific antibiotic selection.
Disclaimer from the AAST Critical Care Committee
The work therefore represents expert opinion and the recommendations of the entire committee. These recommendations are not intended to replace the provider’s clinical experience. The responsible provider must make all treatment decisions based on their independent judgment and a patient’s individual clinical presentation.
Special considerations
Contamination
When choosing an antibiotic regimen, one must take into account special circumstances regarding the type of contamination involved such as salt water/freshwater, clostridial species, or pet/human bites. Water contamination requires coverage for Vibrio, Aeromonas, Pseudomonas, and other species. Trauma involving salt water should be treated with doxycycline and ceftazidime, or a fluoroquinolone. Freshwater wounds should be managed with ciprofloxacin, levofloxacin, or a third-generation or fourth-generation cephalosporin.1 Potential clostridial contamination, such as farm-related injuries, requires high-dose penicillin irrespective of the fracture type.2
A full review of the treatment of bite injuries is beyond the scope of this document, but wounds caused by human, cat, and dog bites (the most common bite wounds encountered) are often treated with antibiotics due to the high load of more variable pathogens found in the oral cavity and the wound mechanism, with punctures that make both natural movement of the bacteria and adequate irrigation difficult.3 A course of 3–5 days of amoxicillin-clavulanate is a suggested regimen, with clindamycin plus trimethoprim-sulfamethoxazole two times per day as an alternative for patients with a penicillin allergy.4 5 While there is increasing question in the literature about the benefit of treating bite injuries with empiric antibiotics, there seems to be general consensus that injuries in high-risk locations (specifically hands, and over cartilage) and in high-risk patients should be treated.4–6 Rabies treatment should also be considered and addressed with any mammalian bite wounds (table 1).
Face and scalp
The evidence for prophylactic antibiotic use for traumatic injuries of the face is heterogeneous and of fairly low quality, and there are no sufficiently powered randomized controlled trials on this topic. As a result, there is tremendous variability in practice patterns among treating surgeons, and many providers continue antibiotic prophylaxis longer than proposed, which leads to overuse of antibiotics in this patient population.7 8
The Surgical Infection Society (SIS) recently published a guideline for prophylactic antibiotic use in patients with traumatic facial fractures.9 The authors of the SIS guidelines defined prophylactic antibiotics as antibiotics administered for more than 24 hours. This was further broken down into preoperative antibiotics (administered more than 1 hour before surgery or 2 hours if receiving vancomycin or quinolones), perioperative antibiotics (administered within 1 hour of surgery, but no more than 24 hours after surgery), and postoperative antibiotics (continued beyond 24 hours after surgery). We use these definitions for the recommendations outlined in this clinical consensus document.
Open or contaminated facial fractures
Are prophylactic antibiotics indicated in the setting of open or contaminated facial fractures?
Recommendations: Fractures of the frontal sinus that involve the posterior table, contaminated fractures, and open mandible fractures should receive 24 hours or less of antibiotics (table 2).
Discussion: Fractures that communicate with the oral cavity or dentate segment of the mandible (ie, angle, body, parasymphysis, and symphysis regions) are often considered open, contaminated wounds, and therefore may place patients at higher risk for osteomyelitis and other infectious complications.10 11 Some studies have reported infection rates as high as 50% for open fractures in the absence of antimicrobial prophylaxis.12 This has led to frequent utilization of antibiotic prophylaxis for these fracture patterns, especially among patients at high risk for infection-related complications (ie, immunosuppression), despite limited data to support this practice. Three small retrospective studies13–15 and one single-center randomized study,16 including patients with mandibular fractures, found that preoperative antibiotics were not associated with a reduction in infection or non-union rates. It is important to note that these studies were all limited by study design, lack of a control group, and inadequate reporting of open fractures.
Two randomized studies of facial fractures limited postoperative antibiotic administration to less than 24 hours which resulted in a significant reduction in infections compared with patients who received no antibiotics.12 17 This may justify the use of antimicrobial prophylaxis until 24 hours after injury; however, continuation beyond this period is not recommended.9 In a review of antibiotic prophylaxis in facial trauma by Goormans et al, none of the included studies found a statistically significant benefit of prolonging antibiotic prophylaxis beyond 24 hours.18 In fact, some studies noted a significantly increased infection rate for patients who received antibiotic prophylaxis for more than 1 day.19–21 In terms of the recommended antibiotic type, no studies have compared the effect of different types of antibiotics on infection rates so the most suitable antibiotic for maxillofacial trauma is unknown.
Closed, non-contaminated, operative facial fractures
Are prophylactic antibiotics indicated in the setting of closed, non-contaminated, operative facial fractures?
Recommendations: Non-contaminated, operative facial fractures do not require postoperative antibiotics.
Discussion: Fractures of the upper one-third of the face (including fractures of the frontal sinus that do not involve the posterior table), middle one-third of the face (including LeFort fractures, zygomaticomaxillary complex fractures, orbital fractures, maxillary sinus wall, and nasal bone fractures), and lower one-third of the face (non-dentate segments of the mandible) are considered non-contaminated fractures and have a lower frequency of postoperative infections.18 Therefore, continuing prophylactic antibiotics beyond 24 hours after surgical fixation is not recommended without documented infection. This is based on findings from multiple studies of mandibular and non-mandibular fractures that found no significant difference in infection rates between patients who received preoperative or postoperative antibiotics versus those who did not.22 23 In fact, one study concluded that a single dose of antibiotics at the time of induction (20 minutes before surgery) is sufficient.24 Soong et al conducted a non-blinded randomized study comparing 1 versus 5 days of postoperative antibiotic use after zygomatic or LeFort fracture repair and found no difference in infection rate between groups.25 The two more recent systematic reviews, one including 13 studies of mandibular and non-mandibular fractures,26 and the other mandibular fractures only,21 also found insufficient evidence to support the use of postoperative antibiotics beyond 24 hours. In fact, the use of antibiotics for >24 hours postoperatively is more costly and may lead to more antibiotic-associated complications.
Non-operative facial fractures
Are prophylactic antibiotics indicated in the setting of non-operative facial fractures?
Recommendations: Prophylactic antibiotics should not be administered for closed, non-operative orbital, upper face, mid-face, or mandibular fractures.
Discussion: The SIS recommends against the use of prophylactic antibiotics for non-operative facial fractures based on the results of two small retrospective studies19 27 and one small single-center randomized study.28 The study by Malekpour et al compared no antibiotics to a short course (1–5 days) or a long course (>5 days) of antibiotics on the incidence of facial soft tissue infection or Clostridium difficile colitis. There were no soft tissue infections in any group. Mandibular and open fractures were excluded, limiting extrapolation to these groups. The study by Zosa et al included 403 patients and compared a short course (single dose or no antibiotics) to extended course (>24 hours) and found no difference in infection rate between treatment groups (3% vs. 5%).
Facial and scalp lacerations
Are prophylactic antibiotics indicated in the setting of facial and scalp lacerations?
Recommendations: Prophylactic antibiotics should be given for through-and-through lacerations from the skin to the oral cavity and in the setting of mammalian bites to the face. Prophylactic antibiotics should not be routinely prescribed for simple facial and scalp lacerations; however, 24 hours or less should be considered in cases with higher infection risk: wounds with significant tissue destruction, large dead space, extensive contamination, or patients with underlying medical problems that increase their risk of infection (table 2).
Discussion: Caruso et al wrote a detailed review of the evidence for prophylactic antibiotic therapy in traumatic craniomaxillofacial injuries in 2022, nicely summarizing the available literature.4 Much of this discussion will draw from that review, as well as the Infectious Disease Society of America guidelines.29 There is a general lack of adequate evidence to guide decision-making for these injuries, and Caruso et al appropriately counsel that thoughtful consideration of the patient, wound, and underlying pathophysiology must be used to make decisions when there is no clear guidance from the data. Compared with injuries to the rest of the body, injuries to the head and neck tend to have the lowest rates of infectious complications.4 This is likely due to the excellent blood supply to this region of the body. For clinical scenarios of ‘normal’ risk (a simple wound in a healthy patient), prophylactic antibiotics do not confer a benefit and should not be used. However, wound characteristics (bites, farming injuries, crush injuries, gross contamination, devitalized tissue, etc) and patient characteristics (diabetes, immunosuppression, steroids, extremes of age, obesity, etc) need to be factored into an assessment of overall infection risk.
One concern with facial lacerations is potential communication with the oral cavity, which carries a significant bacterial load. Lacerations that are confined to the intraoral cavity (including mucous membranes, the lips, and the tongue) and do not communicate with the extraoral environment do not need antibiotics.4 30 Through-and-through lacerations have been considered at higher risk for infection, and therefore antibiotics are often suggested, although this remains controversial given the limited data.4 5 30 31 There are almost no specific data to inform antibiotic prophylaxis for scalp wounds specifically, so it seems reasonable to extrapolate from the management of other traumatic soft tissue wounds. Traumatic cartilage exposure (ear, nose) has historically been treated with prophylactic antibiotics (often fluoroquinolones) in addition to local wound care due to concern for perichondritis. Fluoroquinolones have been used because pseudomonas is a common cause of all-cause perichondritis, but most of these cases are related to piercings, and it is unclear whether the trauma population follows the same microbial pattern.32 33 Evidence to support systemic antibiotics in these injuries is lacking.4 34 Thus, as above, we think a practical approach would be to risk stratify the wound and the patient and use antibiotics only sparingly in truly high-risk situations.
Nasal packing
Are prophylactic antibiotics indicated in the setting of nasal packing?
Recommendations: Prophylactic antibiotics are not recommended in the setting of nasal packing for traumatic epistaxis given a lack of data showing benefit.
Discussion: Nasal packing material is often placed when other efforts at controlling epistaxis have failed. Packing can stay in place for an amount of time varying from a few hours to many days. Infectious concerns with nasal packing include rhinosinusitis, otitis media, and toxic shock syndrome.35 However, multiple recent studies have found routine systemic antibiotic prophylaxis to be neither effective at reducing infection rates nor cost-effective given the risks and complications of antibiotics.35–42 Rates of infection associated with nasal packing are very low at baseline, and cases of toxic shock syndrome secondary to nasal packing are almost non-existent from the last decade.35 41 43 Due to this low infection rate, the many small studies that have attempted to study the role of empiric antibiotic prophylaxis are grossly underpowered to show any significant difference.
Central nervous system
Pneumocephalus
Are prophylactic antibiotics indicated in the setting of pneumocephalus?
Recommendations: Prophylactic antibiotics should not be used in patients with post-traumatic pneumocephalus.
Discussion: Traumatic pneumocephalus is defined as air within the cranial vault and is suggestive of an open skull fracture or communication with the sinuses. Pneumocephalus is often included in studies evaluating the utility of prophylactic antibiotics for basilar skull fractures. Randomized trials evaluating basilar skull fractures by Eftekhar et al and earlier by Hoff et al reported no advantage of the use of antibiotic prophylaxis in patients with traumatic pneumocephalus.44 45 Recently, a large retrospective study evaluated the utility of different prophylactic antibiotic regiments for traumatic pneumocephalus. In addition to demonstrating central nervous system (CNS) infection to be very rare in the setting of traumatic pneumocephalus with an incidence of approximately 1%, the authors found no protective advantage to the use of antibiotic prophylaxis.46
Cerebrospinal fluid leaks
Are prophylactic antibiotics indicated in the setting of cerebrospinal fluid (CSF) leaks?
Recommendations: Prophylactic antibiotics are not recommended in patients with post-traumatic CSF leaks.
Discussion: As mentioned above, basilar skull fractures are thought to predispose patients to CNS infections due to possible direct contact of bacteria in the paranasal sinuses, nasopharynx, or middle ear. CSF leakage has been associated with a greater risk of contracting meningitis, encephalitis, and ventriculitis. CSF leakage often presents clinically as rhinorrhea or otorrhea.47 The incidence of meningitis in patients with post-traumatic CSF leaks varies widely with 10% being a generally accepted rate of infection.47 Antibiotics are often given prophylactically, although their role in preventing bacterial meningitis has not been established. Eftekhar et al evaluated the use of ceftriaxone for meningitis prophylaxis in patients with basilar skull fractures.45 Ceftriaxone has broader gram-negative coverage and CNS penetration. They found no difference in the incidence of meningitis between those who received antibiotics and those who did not when adjusted for the presence of CSF rhinorrhea or otorrhea. Similarly, Demetriades et al using ceftriaxone or ampicillin/sulfadiazine and Klastersky et al using penicillin G evaluated the incidence of meningitis in patients with basilar skull fractures and CSF leaks.48 49 Again, no significant difference in the incidence of meningitis in the antibiotic groups was noted when compared with those who did not receive antibiotics. Lastly, in a Cochrane meta-analysis, no benefit with the use of prophylactic antibiotics was found in patients with basilar skull fractures with or without CSF leakage.50 Ratilal et al found no difference in the frequency of meningitis, all-cause mortality, meningitis-related mortality, and need for surgical correction in patients with CSF leakage with the use of prophylactic antibiotics.50
Penetrating traumatic brain injury
Are prophylactic antibiotics indicated in the setting of penetrating traumatic brain injury (pTBI) to reduce the rate of CNS infection?
Recommendations: A short course of prophylactic antibiotics should be given for pTBI. An extended course of antibiotics, >3 days, does not appear to offer any benefit (table 2).
Discussion: pTBI carries a high risk of infection due to the presence of a foreign body entry into the brain parenchyma. Despite this, controversy continues to exist regarding the use of antibiotic prophylaxis in this patient population as no prospective, randomized data exist to guide management. In 1998, a collaborative effort between national and international traumatic brain injury experts recommended broad-spectrum antibiotics for patients with pTBI without specifying which antibiotic to administer or the duration of use.51 Recent data call into question the benefit of prophylactic antibiotics for pTBI,52 53 thus current recommendations remain inconsistent.
In 2020, Loggini et al performed a systematic review for the management of pTBI concluding that there are no robust data for prophylactic antibiotics.54 In contrast to this recommendation, the US Department of Defense Centers for Excellence for Trauma recommends cefazolin or clindamycin for an unspecified duration. If the wound is visibly contaminated, the guideline suggests the addition of metronidazole.55 The US Army Center for Surgical Research also recommends cefazolin for 5 days if there is gross contamination of the wound.56 More recently, in 2023, Ganga et al performed a PRISMA systematic review to assess the impact of prophylactic antibiotics on reducing risk of CNS infection. The review included 327 cases in which 216 (66%) received prophylactic antibiotics. 38 of the 216 patients who received antibiotics developed infection compared with 21 (19%) who did not (p=0.76). The authors additionally included their institutional experience with 21 patients of which 17 received antibiotics and four did not. All four patients who did not receive antibiotics developed CNS infections, whereas only two out of the 17 with antibiotics (12%) developed infectious complications. The authors concluded that despite insufficient data to support antibiotic use in the literature, the institutional series may benefit from a short course of antibiotics with or without the presence of organic debris.57
The Brain Trauma Foundation (BTF) is the primary organization responsible for brain injury-related guidelines; however, they have not yet published guidelines related to the management of penetrating brain injury (including antibiotic prophylaxis). A Penetrating Brain Injury Expert Workgroup consisting of a collaboration between the BTF along with military and civilian experts has convened and guidelines to address this issue are expected to be published in the near future.58 Thus, current recommendations are considerations based on military consensus and retrospective civilian studies. Antibiotic use for external ventricular drainage (EVD), ventriculoperitoneal (VP) shunts and their associated infection risk are discussed in the other articles in this series, Fever and Infections in Surgical Intensive Care and Surgical and Procedural Antibiotic Prophylaxis in the Surgical ICU by Nohra et al 59 and Farrell et al, 60 respectively.
Penetrating spine injury
Are prophylactic antibiotics indicated in the setting of penetrating spine injury?
Recommendations: Prophylactic antibiotics, no longer than 48 hours, are recommended for low-velocity gunshot wounds (GSW) to the spine (table 2).
Discussion: There has long been clinical concern regarding GSWs to the spine, especially those with gastrointestinal involvement, and the potential to develop spinal or paraspinal infections. As a result, much of the spine literature has advocated prolonged courses of ‘prophylactic’ antibiotics lasting up to 14 days to prevent infection with the greatest concern involving transcolonic injuries.61 As no prospective studies exist, these recommendations are based on clinical judgment, older retrospective studies and case series that are underpowered and use varying antibiotic courses lasting up to 6 weeks. The incidence of infection without antibiotic use after penetrating injury is not known which further hampers the interpretation of any available information regarding the necessity or duration of antibiotic use. Additionally, there is very little information regarding stab wounds to the spine and the necessity of antimicrobial prophylaxis.
More recent studies have demonstrated a low incidence of spinal infection with a shorter duration of antibiotic use. In larger retrospective studies with adequate follow-up, Rabinowitz et al and Pasupuleti et al both demonstrated a very low rate of spine infection after transperitoneal, low-velocity GSWs to the spine including those with gastrointestinal involvement with courses of prophylactic antibiotic therapy lasting no more than 48 hours.62 63 Admittedly, some patients received antibiotics for longer durations, but for treatment of infections acquired after admission unrelated to the spine. Antibiotics used in these studies included first and second-generation cephalosporins, ampicillin-sulbactam, piperacillin-tazobactam, and clindamycin with second-generation cephalosporins being used most commonly.
In another large retrospective study, Quigley and Place evaluated the incidence of spine infections after low-velocity GSWs.64 Patients were separated into two groups with those receiving adequate (5 days) or inadequate (<5 days) prophylactic antibiotics, as described by the author. No information was provided regarding the antibiotics used. Spinal infections only occurred in those with gastrointestinal involvement; however, equivalent rates of spinal infection (12% vs. 15%) were noted irrespective of the length of coverage. As such, the authors concluded a greater risk of infection with GSWs that involve the gastrointestinal tract and longer courses of therapy do not necessarily mitigate the risk. Earlier studies also support these findings.65 A recent meta-analysis by Mahmood et al evaluated the duration of antibiotics for penetrating spine injuries and concluded that no formal recommendations could be made, but 48 hours appeared appropriate with the only possible exception being transcolonic injuries.61 This caveat, however, is not supported by the findings of Rabinowitz and Pasupuleti. Ultimately, an adequately powered, prospective study that evaluates the necessity, type, and length of therapy is needed.
Extremity
Are prophylactic antibiotics indicated in the setting of extremity fracture?
Recommendations: Closed extremity fractures require preoperative antibiotics within 1 hour of incision. Open extremity fractures should be graded based on the Gustilo classification system and treated with antibiotics based on the fracture severity. Types I and II should be treated with gram-positive coverage; while type III should be treated with gram-positive and gram-negative coverage. Antibiotics should be initiated within 1 hour of injury and continued for 24 hours. Washout and debridement should take place within 24 hours of injury. Antibiotics should not be continued >24 hours after soft tissue coverage. Depending on the type of contamination, the antibiotic regimen may need to be further adjusted (table 2).
Discussion: In 1976, Gustilo and Anderson created a system to classify open extremity fractures based on the size of the associated laceration, the degree of soft tissue injury, contamination, and presence of vascular compromise.66 Gustilo et al refined the classification of severe open fractures, see box 1 67, and became the most common method to determine the type of antibiotics needed based on open fracture severity.68 Type I fractures are those fractures from low-energy mechanisms, with <1 cm wounds and no gross contamination. Type II fractures are those with 1–10 cm wounds that lack gross contamination or extensive soft tissue damage, flaps or avulsions. Type III open fractures include those with wounds greater than 10 cm with extensive soft tissue damage, traumatic amputation, or any open fracture due to high-energy trauma (including high-velocity ballistic injuries), or any size wound with gross contamination.66–68
Box 1. Gustilo classification.
-
Type I
Open fracture with skin wound ≤1 cm, clean.
-
Type II
Open fracture with wound 1–10 cm, without extensive soft tissue damage, flaps, or avulsions.
-
Type III
Open fracture with wound >10 cm, with extensive soft tissue injury or amputation.
-
IIIA
Adequate tissue for flap coverage.
Farm injuries (at least Gustilo IIIA).
-
IIIB
Significant soft tissue loss with exposed bone that requires soft tissue coverage.
-
IIIC
Associated vascular injury requiring vascular repair, regardless of degree of soft tissue injury.
Closed fractures do not require antibiotics at presentation; however, preoperative antibiotics should be given within 1 hour of incision and first-generation cephalosporins are recommended.69 All patients who sustain an open fracture, without a contraindication, should receive gram-positive antibiotic coverage within 1 hour of injury.2 Additional gram-negative coverage should be added for type III fractures.2 69 Fluoroquinolones offer no advantage compared with cephalosporin/aminoglycoside regimens.2 70 71 Moreover, fluoroquinolones may have a detrimental effect on fracture healing and may result in higher infection rates in type III open fractures.2 72 73 The preferred antibiotic for these fractures has typically been piperacillin/tazobactam due to its association with a lower risk of delayed wound healing.74 However, recent data suggest that ceftriaxone monotherapy is an acceptable alternative.2 75 Although some centers incorporate vancomycin into their prophylaxis algorithms for more severe fractures, the data supporting this practice are limited.
There is growing evidence that suggests the original ‘six hour rule’ for washout and debridement is based on historical perspectives, and numerous studies have failed to support this timeframe.76 77 New evidence continues to show that washout and debridement of open fractures within 24 hours does not increase infectious complications.78 79 Additional studies demonstrate no more than 24 hours of antibiotic coverage is required with many showing that a single dose of antibiotics prior to incision is sufficient.80 81 The duration of antimicrobial coverage >72 hours does not further reduce the risk of infection, even in patients in whom soft tissue coverage has not been achieved.2 82 Antimicrobials should be not be continued >24 hours beyond soft tissue coverage.2
Soft tissue injury
Of note, the focus of this section is on civilian trauma, with the acknowledgment that military-grade (ie, higher energy) weapons are sometimes used in civilian trauma. Further, this review will focus on isolated soft tissue injuries that are not associated with underlying bony or hollow viscus injury.
Simple lacerations (other than face and scalp)
Are prophylactic antibiotics indicated in the setting of simple lacerations?
Recommendations: Prophylactic antibiotics are not suggested in simple soft tissue lacerations. The exceptions to this recommendation are specific wound-related concerns or underlying patient factors that would increase the risk in which 24 hours or less of antibiotics would be appropriate (table 2).
Discussion: There are no recent data to support prophylactic antibiotics for uncomplicated, traumatic soft tissue lacerations. Most high-quality evidence on this topic is over 20 years old, and supports avoiding antibiotics,5 6 while much of the recent literature is focused on soft tissue injury with underlying open fractures but does not address isolated soft tissue injury.83 Overall, the studies emphasize the importance of adequate irrigation, debridement, removal of foreign bodies, and appropriate closure technique as the major means of infection prevention. While the little data that exist generally support forgoing antibiotic prophylaxis, it is important to identify the cases that are more complex and thus may have different management considerations. Moran et al 3 provide a useful approach, advising the consideration of both high-risk wounds and high-risk patients, which may affect a clinician’s decision to give antibiotic prophylaxis. The WHO provides a similar framework for wound assessment that includes size, contamination, and other high-risk factors.84 Clinicians should work from a baseline understanding that in most simple, traumatic soft tissue wounds in civilian patients, prophylactic antibiotics are likely unnecessary, and then adjust only on the basis of specific patient-related or wound-related risk factors or concerns. Additionally, tetanus status should be queried and addressed.
Stab wounds
Are prophylactic antibiotics indicated in the setting of stab wounds?
Recommendations: Prophylactic antibiotics are not suggested in simple stab wounds that involve only soft tissue. The exceptions to this recommendation are specific wound-related concerns or underlying patient factors that would increase the risk in which 24 hours or less of antibiotics would be appropriate (table 2).
Discussion: Stab wounds can range from small but deep lacerations to more shallow wounds akin to simple lacerations. They are caused by objects of variable cleanliness. Like all wounds, irrigation and debridement of any devitalized tissue are paramount for infection prevention. Adequate irrigation of the deepest portions of stab wounds can be challenging without extension of the skin defect, and opening the wound further may require sedation or a trip to the operating room. This added morbidity must be weighed against potential benefit. Deeper wounds are at higher risk of infection.85 The nature of the penetrating object, if known, as well as the extent and type of contamination, might sway a clinician’s decision about antibiotics if there is a particular concern (eg, contamination with soil or aquatic microbes). Stab wounds that communicate with deeper body cavities or structures are generally managed based on the underlying injury. As mentioned above, tetanus status should be queried and addressed.
Gunshot wounds
Are prophylactic antibiotics indicated in the setting of GSWs?
Recommendations: The data are inconclusive regarding the risk of infection with low-velocity GSWs; hence, we recommend careful consideration of antibiotic prophylaxis for these wounds. Factors such as amount of tissue destruction, extent of contamination, timing since injury, anatomic location of the wound(s), and muzzle velocity, among others, may increase infectious risk enough to warrant antimicrobial prophylaxis for one or more systemic doses. Appropriate local wound management in accordance with these factors is a key principle in management (table 2).
Discussion: A popular myth is that the heat produced by the bullet kills bacteria—it does not; the bullet is contaminated, especially wadding in the setting of shotguns.86–88 After GSW, substantial quantities of aerobic and anaerobic organisms have been reported in wounds after several hours.87 Adequate surgical wound management is essential; however, it remains unclear whether empiric antibiotic prophylaxis improves infectious outcomes. Nguyen et al illustrated the lack of clarity in this realm with a survey of orthopedic trauma association members on the management of GSWs without underlying fractures.89 One study, although underpowered, included 60 low-velocity GSW injuries to the extremities and demonstrated a relatively high 26% infection rate without antibiotics versus 6% infection rates with prophylactic antibiotics.90 Others indicate lower infection rates that may be further reduced with antibiotics.86 87
While the literature is inconclusive for low-energy wounds, there is support for prophylactic antibiotic usage when wounds are complex, are of higher energy, have anatomic location such as hands/feet, and/or have other high-risk features mentioned above.86 87 Higher energy GSWs are associated with increased infection rates, at least in part because the increased mass of devitalized tissue creates an excellent medium for bacterial growth without full host defenses. For high-energy wounds, 24–72 hours of systemic antibiotics have been recommended.86 89 91 However, previous studies have indicated that only in a fraction of cases could the type of weapon be accurately determined,87 so ultimately most of these judgments must rely on examination of the wound. This led to the axiom to treat ‘the wound and not the weapon’ from Lindsey.92 Even if the degree of tissue contamination and tissue destruction merit antibiotic prophylaxis, antibiotics alone, without adequate debridement, would be insufficient.86 When antibiotic prophylaxis is determined necessary for lower energy GSWs, a first-generation cephalosporin (or clindamycin in the setting of a penicillin allergy) generally is sufficient.93 Appropriate duration is unclear and likely needs to be determined based on the same considerations described above.90 94 Tetanus vaccination status should be addressed.87
Burn injury
Are prophylactic antibiotics indicated in the setting of burn injury?
Recommendations: Routine use of prophylactic antibiotics is not recommended for burn patients.
Discussion: Burn injury results in a massive inflammatory response as well as the loss of physical barriers (skin and airway mucosa) to infection. Bacterial translocation from the gut contributes to the risk of sepsis.95 These risks have led to a continued interest in the use of prophylactic antibiotics for burn patients in the ICU; however, the practice remains controversial. In 2010, Avni et al published a meta-analysis demonstrating reduced all-cause mortality based on five studies.96 There was a reduced rate of pneumonia based on four studies, but no overall effect on bacteremia. The included studies spanned approximately 40 years and were of relatively low quality. Perhaps more important was the significant increase in resistant organisms after prophylactic antibiotics. Subsequent meta-analyses in 2013, 2017, 2020 and one of pediatric patients in 2019 failed to show a benefit to systemic prophylaxis for the prevention of mortality.6 97–99 In each of these studies there was significant variation in the type of prophylaxis used as well as the overall severity of the burns. While there is some evidence for the reduction of mortality in severely burned patients requiring mechanical ventilation with prophylactic antibiotics, no difference was found in patients not mechanically ventilated, and the effects on antibiotic resistance remain unknown.98 100 Many consensus statements also agree that routine systemic prophylaxis should not be used in burn patients.101–103
Footnotes
Contributors: All authors were involved in the design, research, and writing of this guideline, as well as critical revision of the article. RDA, MSF, EAN, JC and DMS performed the final revisions of the article.
Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Disclaimer: RBG reports Honoraria for Lectures/presentations: Morristown Memorial Hospital – Keynote speaker honorarium Payment made to me; Leadership in Board/Society: Chair, Scientific Studies Committee, Surgical Infection Society - unpaid; Payment for Expert Testimony: Billing, Cochran, Lyles, Mauro & Ramsey PA; Rafi Law Firm; Foy & Associates P.C. SM reports UpToDate – Author Royalty; AHRQ grant funding, but not related to this topic TR reports “I received an honorarium from Stanford Hospital / Santa Clara Valley Medical Center for speaking at their annual trauma; support from my home institution (UC Davis) for attendance at meetings (WTA in 2022, 2023)” DMS reports grant funding from PCORI, DoD, NIH, NHTSA and Consultant fees - CSL Behring
Competing interests: RG reports honoraria for lectures/presentations: Morristown Memorial Hospital—keynote speaker honorarium, payments made to the author; Leadership in Board/Society: Chair, Scientific Studies Committee, Surgical Infection Society—unpaid; Payment for Expert Testimony: Billing, Cochran, Lyles, Mauro & Ramsey PA; Rafi Law Firm; Foy & Associates PC. SM reports UpToDate—author royalty; AHRQ grant funding, but not related to this topic. TR reports receiving an honorarium from Stanford Hospital/Santa Clara Valley Medical Center for speaking at their annual trauma; support from the author's home institution (UC Davis) for attendance at meetings (WTA in 2022, 2023). DMS reports grant funding from PCORI, DoD, NIH, and NHTSA and consultant fees from CSL Behring.
Provenance and peer review: Not commissioned; externally peer reviewed.
Ethics statements
Patient consent for publication
Not applicable.
References
- 1. Noonburg GE. Management of extremity trauma and related infections occurring in the aquatic environment. J Am Acad Orthop Surg 2005;13:243–53. 10.5435/00124635-200507000-00004 [DOI] [PubMed] [Google Scholar]
- 2. Hoff WS, Bonadies JA, Cachecho R, Dorlac WC. East practice management guidelines work group: update to practice management guidelines for prophylactic antibiotic use in open fractures. J Trauma 2011;70:751–4. 10.1097/TA.0b013e31820930e5 [DOI] [PubMed] [Google Scholar]
- 3. Moran GJ, Talan DA, Abrahamian FM. Antimicrobial prophylaxis for wounds and procedures in the emergency Department. Infect Dis Clin North Am 2008;22:117–43, 10.1016/j.idc.2007.12.002 [DOI] [PubMed] [Google Scholar]
- 4. Caruso DP, Aquino VM, Tannyhill RJI. Algorithmic approach to antibiotic prophylaxis for traumatic Craniomaxillofacial injuries. J Craniofac Surg 2022;33:1082–9. 10.1097/SCS.0000000000008432 [DOI] [PubMed] [Google Scholar]
- 5. Nakamura Y, Daya M. Use of appropriate antimicrobials in wound management. Emerg Med Clin North Am 2007;25:159–76. 10.1016/j.emc.2007.01.007 [DOI] [PubMed] [Google Scholar]
- 6. Cicuttin E, Sartelli M, Scozzafava E, Tartaglia D, Cremonini C, Brevi B, Ramacciotti N, Musetti S, Strambi S, Podda M, et al. Antibiotic prophylaxis in torso, Maxillofacial, and skin traumatic lesions: A systematic review of recent evidence. Antibiotics (Basel) 2022;11:139. 10.3390/antibiotics11020139 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Mundinger GS, Borsuk DE, Okhah Z, Christy MR, Bojovic B, Dorafshar AH, Rodriguez ED. Antibiotics and facial fractures: evidence-based recommendations compared with experience-based practice. Craniomaxillofac Trauma Reconstr 2015;8:64–78. 10.1055/s-0034-1378187 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Shridharani SM, Berli J, Manson PN, Tufaro AP, Rodriguez ED. The role of postoperative antibiotics in mandible fractures: A systematic review of the literature. Ann Plast Surg 2015;75:353–7. 10.1097/SAP.0000000000000135 [DOI] [PubMed] [Google Scholar]
- 9. Forrester JD, Wolff CJ, Choi J, Colling KP, Huston JM. Surgical infection society guidelines for antibiotic use in patients with traumatic facial fractures. Surgical Infections 2021;22:274–82. 10.1089/sur.2020.107 [DOI] [PubMed] [Google Scholar]
- 10. Dougherty WM, Christophel JJ, Park SS. Evidence-based medicine in facial trauma. Facial Plast Surg Clin North Am 2017;25:629–43.:S1064-7406(17)30064-0. 10.1016/j.fsc.2017.06.013 [DOI] [PubMed] [Google Scholar]
- 11. Chukwulebe S, Hogrefe C. The diagnosis and management of facial bone fractures. Emerg Med Clin North Am 2019;37:137–51.:S0733-8627(18)30099-3. 10.1016/j.emc.2018.09.012 [DOI] [PubMed] [Google Scholar]
- 12. Chole RA, Yee J. Antibiotic prophylaxis for facial fractures. A prospective, randomized clinical trial. Archives of Otolaryngology - Head and Neck Surgery 1987;113:1055–7. 10.1001/archotol.1987.01860100033016 [DOI] [PubMed] [Google Scholar]
- 13. Furr AM, Schweinfurth JM, May WL. Factors associated with long-term complications after repair of Mandibular fractures. The Laryngoscope 2006;116:427–30. 10.1097/01.MLG.0000194844.87268.ED [DOI] [PubMed] [Google Scholar]
- 14. Gaal A, Bailey B, Patel Y, Smiley N, Dodson T, Kim D, Dillon J. Limiting antibiotics when managing mandible fractures may not increase infection risk. Journal of Oral and Maxillofacial Surgery 2016;74:2008–18. 10.1016/j.joms.2016.05.019 [DOI] [PubMed] [Google Scholar]
- 15. Linkugel AD, Odom EB, Bavolek RA, Snyder-Warwick AK, Patel KB. Systemic preoperative antibiotics with mandible fractures: are they indicated at the time of injury Craniomaxillofacial Trauma & Reconstruction 2018;11:035–40. 10.1055/s-0037-1603458 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Mamthashri V, Reddy BP. Comparison of preoperative and perioperative antibiotic prophylaxis regimen in compound facial fractures. J Contemp Dent Pract 2018;19:214–20. 10.5005/jp-journals-10024-2239 [DOI] [PubMed] [Google Scholar]
- 17. Gerlach K, Pape H. Perioperative antibiotic prophylaxis in Mandibular fracture treatment. Chemioterapia 1987;6:568. [PubMed] [Google Scholar]
- 18. Goormans F, Coropciuc R, Vercruysse M, Spriet I, Willaert R, Politis C. Systemic antibiotic prophylaxis in Maxillofacial trauma: A. Scoping Review and Critical Appraisal Antibiotics 2022;11:483. 10.3390/antibiotics11040483 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Zosa BM, Elliott CW, Kurlander DE, Johnson F, Ho VP, Claridge JA. Facing the facts on prophylactic antibiotics for facial fractures: 1 day or less. J Trauma Acute Care Surg 2018;85:444–50. 10.1097/TA.0000000000002009 [DOI] [PubMed] [Google Scholar]
- 20. Miles BA, Potter JK, Ellis E. The efficacy of postoperative antibiotic regimens in the open treatment of Mandibular fractures: a prospective randomized trial. Journal of Oral and Maxillofacial Surgery 2006;64:576–82. 10.1016/j.joms.2006.01.003 [DOI] [PubMed] [Google Scholar]
- 21. Delaplain PT, Phillips JL, Lundeberg M, Nahmias J, Kuza CM, Sheehan BM, Murphy LS, Pejcinovska M, Grigorian A, Gabriel V, et al. No reduction in surgical site infection obtained with post-operative antibiotics in facial fractures, regardless of duration or anatomic location: a systematic review and meta-analysis. Surgical Infections 2020;21:112–21. 10.1089/sur.2019.149 [DOI] [PubMed] [Google Scholar]
- 22. Lauder A, Jalisi S, Spiegel J, Stram J, Devaiah A. Antibiotic prophylaxis in the management of complex Midface and frontal sinus trauma. Laryngoscope 2010;120:1940–5. 10.1002/lary.21081 [DOI] [PubMed] [Google Scholar]
- 23. Knepil GJ, Loukota RA. Outcomes of prophylactic antibiotics following surgery for Zygomatic bone fractures. J Craniomaxillofac Surg 2010;38:131–3. 10.1016/j.jcms.2009.03.015 [DOI] [PubMed] [Google Scholar]
- 24. Campos GB, Lucena EE, da Silva JSP, Gomes PP, Germano AR. Efficacy assessment of two antibiotic prophylaxis regimens in oral and Maxillofacial trauma surgery: preliminary results. Int J Clin Exp Med 2015;8:2846–52. [PMC free article] [PubMed] [Google Scholar]
- 25. Soong PL, Schaller B, Zix J, Iizuka T, Mottini M, Lieger O. The role of postoperative prophylactic antibiotics in the treatment of facial fractures: a randomized, double-blind, placebo-controlled pilot clinical study. part 3: Le Fort and Zygomatic fractures in 94 patients. Br J Oral Maxillofac Surg 2014;52:329–33.:S0266-4356(14)00036-9. 10.1016/j.bjoms.2014.01.010 [DOI] [PubMed] [Google Scholar]
- 26. Habib AM, Wong AD, Schreiner GC, Satti KF, Riblet NB, Johnson HA, Ossoff JP. Postoperative prophylactic antibiotics for facial fractures: a systematic review and meta-analysis. Laryngoscope 2019;129:82–95. 10.1002/lary.27210 [DOI] [PubMed] [Google Scholar]
- 27. Malekpour M, Bridgham K, Neuhaus N, Widom K, Rapp M, Leonard D, Baro S, Dove J, Hunsinger M, Blansfield J, et al. Utility of prophylactic antibiotics in Nonoperative facial fractures. J Craniofac Surg 2016;27:1677–80. 10.1097/SCS.0000000000002724 [DOI] [PubMed] [Google Scholar]
- 28. Schmidt RS, Dodson KM, Goldman RA. Prophylactic antibiotic therapy for fractures of the Maxillary sinus. Ear Nose Throat J 2015;94:170–7. [PubMed] [Google Scholar]
- 29. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clinical Infectious Diseases Oxford Academic; [DOI] [PubMed]
- 30. Katsetos SL, Nagurka R, Caffrey J, Keller SE, Murano T. Antibiotic prophylaxis for oral lacerations: our emergency Department’s experience. Int J Emerg Med 2016;9:24. 10.1186/s12245-016-0122-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Colmers-Gray IN, Crawshay A, Budden C. Minor injuries: laceration repairs. BMJ 2023;380:e067573. 10.1136/bmj-2021-067573 [DOI] [PubMed] [Google Scholar]
- 32. Fisher CG, Kacica MA, Bennett NM. Risk factors for cartilage infections of the ear. Am J Prev Med 2005;29:204–9. 10.1016/j.amepre.2005.06.003 [DOI] [PubMed] [Google Scholar]
- 33. Nojoumi A, Woo BM. Management of ear trauma. Oral and Maxillofacial Surgery Clinics of North America 2021;33:305–15. 10.1016/j.coms.2021.04.001 [DOI] [PubMed] [Google Scholar]
- 34. Bhattacharya V. Management of soft tissue wounds of the face. Indian J Plast Surg 2012;45:436–43. 10.4103/0970-0358.105936 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Cohn B. Are prophylactic antibiotics necessary for anterior nasal packing in Epistaxis Ann Emerg Med 2015;65:109–11.:S0196-0644(14)01155-X. 10.1016/j.annemergmed.2014.08.011 [DOI] [PubMed] [Google Scholar]
- 36. Biggs T, Nightingale K, Patel N, Salib R. Should prophylactic antibiotics be used routinely in Epistaxis patients with nasal packs Annals 2013;95:40–2. 10.1308/003588413X13511609954734 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Swaminathan A. MYTHS IN EMERGENCY MEDICINE: no antibiotics needed for nasal packing. Emergency Medicine News 2016;38:8. 10.1097/01.EEM.0000484518.94358.49 [DOI] [Google Scholar]
- 38. Biswas D, Mal RK. Are systemic prophylactic antibiotics indicated with anterior nasal packing for spontaneous Epistaxis? Acta Otolaryngol 2009;129:179–81. 10.1080/00016480802043964 [DOI] [PubMed] [Google Scholar]
- 39. Pepper C, Lo S, Toma A. Prospective study of the risk of not using prophylactic antibiotics in nasal packing for Epistaxis. J Laryngol Otol 2012;126:257–9. 10.1017/S0022215111003215 [DOI] [PubMed] [Google Scholar]
- 40. Murano T, Brucato-Duncan D, Ramdin C, Keller S. Prophylactic systemic antibiotics for anterior Epistaxis treated with nasal packing in the ED. Am J Emerg Med 2019;37:726–9.:S0735-6757(18)31034-9. 10.1016/j.ajem.2018.12.056 [DOI] [PubMed] [Google Scholar]
- 41. Pérez F, Rada G. Is antibiotic prophylaxis in nasal packing for anterior Epistaxis needed Medwave 2016;16 Suppl 1:e6357. 10.5867/medwave.2015.6357 [DOI] [PubMed] [Google Scholar]
- 42. Maul X, Dincer BC, Wu AW, Thamboo AV, Higgins TS, Scangas GA, Oliveira K, Ho AS, Mallen-St Clair J, Walgama E. A clinical decision analysis for use of antibiotic prophylaxis for Nonabsorbable nasal packing. Otolaryngol Head Neck Surg 2021;165:647–54. 10.1177/0194599820988740 [DOI] [PubMed] [Google Scholar]
- 43. Tran QK, Rehan MA, Haase DJ, Matta A, Pourmand A. Prophylactic antibiotics for anterior nasal packing in emergency Department: A systematic review and meta-analysis of clinically-significant infections. Am J Emerg Med 2020;38:983–9.:S0735-6757(19)30776-4. 10.1016/j.ajem.2019.11.037 [DOI] [PubMed] [Google Scholar]
- 44. Hoff JT, Brewin A, U HS. Antibiotics for basilar skull fracture (letter). J Neurosurg 1976;44:649. 10.3171/jns.1976.44.5.0649 [DOI] [PubMed] [Google Scholar]
- 45. Eftekhar B, Ghodsi M, Nejat F, Ketabchi E, Esmaeeli B. Prophylactic administration of Ceftriaxone for the prevention of meningitis after traumatic Pneumocephalus: results of a clinical trial. J Neurosurg 2004;101:757–61. 10.3171/jns.2004.101.5.0757 [DOI] [PubMed] [Google Scholar]
- 46. Wang HP, Reif RJ, Kalkwarf KJ, Jensen HK, Jenkins AK, Bhavaraju A. Prophylactic antibiotics in patients with traumatic Pneumocephalus or cerebrospinal fluid leak. The American Surgeon TM 2023;89:3037–42. 10.1177/00031348221117041 [DOI] [PubMed] [Google Scholar]
- 47. Prosser JD, Vender JR, Solares CA. Traumatic cerebrospinal fluid leaks. Otolaryngologic Clinics of North America 2011;44:857–73. 10.1016/j.otc.2011.06.007 [DOI] [PubMed] [Google Scholar]
- 48. Demetriades D, Charalambides D, Lakhoo M, Pantanowitz D. Role of prophylactic antibiotics in open and basilar fractures of the skull: a randomized study. Injury 1992;23:377–80. 10.1016/0020-1383(92)90011-G [DOI] [PubMed] [Google Scholar]
- 49. Klastersky J, Sadeghi M, Brihaye J. Antimicrobial prophylaxis in patients with Rhinorrhea or Otorrhea: a double blind study. Surg Neurol 1976;6:111–4. [PubMed] [Google Scholar]
- 50. Ratilal BO, Costa J, Pappamikail L, Sampaio C. Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures. Cochrane Database Syst Rev 2015;2015:CD004884. 10.1002/14651858.CD004884.pub4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Marut D, Shammassian B, McKenzie C, Adamski J, Traeger J. Evaluation of prophylactic antibiotics in penetrating brain injuries at an academic level 1 trauma center. Clin Neurol Neurosurg 2020;193:105777.:S0303-8467(20)30120-7. 10.1016/j.clineuro.2020.105777 [DOI] [PubMed] [Google Scholar]
- 52. Takahashi CE, Virmani D, Chung DY, Ong C, Cervantes-Arslanian AM. Blunt and penetrating severe traumatic brain injury. Neurol Clin 2021;39:443–69.:S0733-8619(21)00021-9. 10.1016/j.ncl.2021.02.009 [DOI] [PubMed] [Google Scholar]
- 53. Antibiotic prophylaxis for penetrating brain injury. The Journal of Trauma: Injury, Infection, and Critical Care 2001;51:S34–40. 10.1097/00005373-200108001-00009 [DOI] [PubMed] [Google Scholar]
- 54. Loggini A, Vasenina VI, Mansour A, Das P, Horowitz PM, Goldenberg FD, Kramer C, Lazaridis C. Management of civilians with penetrating brain injury: A systematic review. Journal of Critical Care 2020;56:159–66. 10.1016/j.jcrc.2019.12.026 [DOI] [PubMed] [Google Scholar]
- 55. McCafferty RR, Neal CJ, Marshall SA, Pamplin JC, Rivet D, Hood BJ, Cooper PB, Stockinger Z. Neurosurgery and medical management of severe head injury. Mil Med 2018;183:67–72. 10.1093/milmed/usy071 [DOI] [PubMed] [Google Scholar]
- 56. Hospenthal DR, Murray CK, Andersen RC, Blice JP, Calhoun JH, Cancio LC, Chung KK, Conger NG, Crouch HK, D’Avignon LC, et al. Guidelines for the prevention of infection after combat-related injuries. J Trauma 2008;64:S211–20. 10.1097/TA.0b013e318163c421 [DOI] [PubMed] [Google Scholar]
- 57. Ganga A, Leary OP, Sastry RA, Asaad WF, Svokos KA, Oyelese AA, Mermel LA. Antibiotic prophylaxis in penetrating traumatic brain injury: analysis of a single-center series and systematic review of the literature. Acta Neurochir (Wien) 2023;165:303–13. 10.1007/s00701-022-05432-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Hawryluk GWJ, Selph S, Lumba-Brown A, Totten AM, Ghajar J, Aarabi B, Ecklund J, Shackelford S, Adams B, Adelson D, et al. Rationale and methods for updated guidelines for the management of penetrating traumatic brain injury. Neurotrauma Rep 2022;3:240–7. 10.1089/neur.2022.0008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Nohra E, Appelbaum RD, Farrell MS, et al. Fever and infections in surgical intensive care: an American Association for the surgery of trauma critical care committee clinical consensus document. Trauma Surg Acute Care Open 2024;0:e001303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Farrell MS, Agapian JV, Appelbaum RD, et al. Surgical and procedural antibiotic prophylaxis in the surgical ICU: an American Association for the surgery of trauma critical care committee clinical consensus document. Trauma Surg Acute Care Open 2024;0:e001305. [Google Scholar]
- 61. Mahmood B, Weisberg M, Baribeau Y, Buehring W, Razi A, Saleh A. Duration of antibiotics for penetrating spine trauma: a systematic review. J Spine Surg 2020;6:606–12. 10.21037/jss-20-451 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Rabinowitz RP, Tabatabai A, Stein DM, Scalea TM. Infectious complications in GSW’s through the gastrointestinal tract into the spine. Injury 2012;43:1058–60. 10.1016/j.injury.2012.01.014 [DOI] [PubMed] [Google Scholar]
- 63. Pasupuleti LV, Sifri ZC, Mohr AM. Is extended antibiotic prophylaxis necessary after penetrating injury to the Thoracolumbar spine with concomitant intraperitoneal injuries Surgical Infections 2014;15:8–13. 10.1089/sur.2012.139 [DOI] [PubMed] [Google Scholar]
- 64. Quigley KJ, Place HM. The role of Debridement and antibiotics in gunshot wounds to the spine. J Trauma 2006;60:814–9; 10.1097/01.ta.0000195472.99198.71 [DOI] [PubMed] [Google Scholar]
- 65. Lin SS, Vaccaro AR, Reisch S, Devine M, Cotler JM. Low-velocity gunshot wounds to the spine with associated Transperitoneal injury. Journal of Spinal Disorders 1995;8:136 10.1097/00002517-199504000-00008 [DOI] [PubMed] [Google Scholar]
- 66. Gustilo RB, Anderson JT. Prevention of infection in the treatment of 1025 open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am 1976;58:453–8. [PubMed] [Google Scholar]
- 67. Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma 1984;24:742–6. 10.1097/00005373-198408000-00009 [DOI] [PubMed] [Google Scholar]
- 68. Gustilo RB, Gruninger RP, Davis T. Classification of type III (severe) open fractures relative to treatment and results. Orthopedics 1987;10:1781–8. [PubMed] [Google Scholar]
- 69. Vasenius J, Tulikoura I, Vainionpää S, Rokkanen P. Clindamycin versus Cloxacillin in the treatment of 240 open fractures. A randomized prospective study. Ann Chir Gynaecol 1998;87:224–8. [PubMed] [Google Scholar]
- 70. Sorger JI, Kirk PG, Ruhnke CJ, Bjornson SH, Levy MS, Cockrin J, Tang P. Once daily, high dose versus divided low dose gentamicin for open fractures. Clin Orthop Relat Res 1999;366:197–204. 10.1097/00003086-199909000-00026 [DOI] [PubMed] [Google Scholar]
- 71. Russell GV, King C, May CG, Pearsall AW. Once daily high-dose gentamicin to prevent infection in open fractures of the Tibial shaft: a preliminary investigation. Southern Medical Journal 2001;94:1185–91. 10.1097/00007611-200194120-00012 [DOI] [PubMed] [Google Scholar]
- 72. Patzakis MJ, Bains RS, Lee J, Shepherd L, Singer G, Ressler R, Harvey F, Holtom P. Prospective, randomized, double blind study comparing single-agent antibiotic therapy, ciprofloxacin, to combination antibiotic therapy in open fracture wounds. J Orthop Trauma 2000;14:529–33. 10.1097/00005131-200011000-00002 [DOI] [PubMed] [Google Scholar]
- 73. Huddleston PM, Steckelberg JM, Hanssen AD, Rouse MS, Bolander ME, Patel R. Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am 2000;82:161–73. 10.2106/00004623-200002000-00002 [DOI] [PubMed] [Google Scholar]
- 74. Frantz TL, Everhart JS, Kanney JM, McDermott SM, Phieffer LS, Ly TV. Early complications of antibiotic prophylaxis with Cefazolin protocols versus piperacillin-Tazobactam for open fractures: A retrospective comparative study. Curr Orthop Pract 2020;31:549–55. 10.1097/BCO.0000000000000932 [DOI] [Google Scholar]
- 75. Rodriguez L, Jung HS, Goulet JA, Cicalo A, Machado-Aranda DA, Napolitano LM. Evidence-based protocol for prophylactic antibiotics in open fractures: improved antibiotic stewardship with no increase in infection rates. J Trauma Acute Care Surg 2014;77:400–7. 10.1097/TA.0000000000000398 [DOI] [PubMed] [Google Scholar]
- 76. Crowley DJ, Kanakaris NK, Giannoudis PV. Debridement and wound closure of open fractures: the impact of the time factor on infection rates. Injury 2007;38:879–89. 10.1016/j.injury.2007.01.012 [DOI] [PubMed] [Google Scholar]
- 77. Al-Arabi YB, Nader M, Hamidian-Jahromi AR, Woods DA. The effect of the timing of antibiotics and surgical treatment on infection rates in open long-bone fractures: a 9-year prospective study from a district general hospital. Injury 2007;38:900–5. 10.1016/j.injury.2007.02.043 [DOI] [PubMed] [Google Scholar]
- 78. Skaggs DL, Friend L, Alman B, Chambers HG, Schmitz M, Leake B, Kay RM, Flynn JM. The effect of surgical delay on acute infection following 554 open fractures in children. The Journal of Bone & Joint Surgery 2005;87:8–12. 10.2106/JBJS.C.01561 [DOI] [PubMed] [Google Scholar]
- 79. Srour M, Inaba K, Okoye O, Chan C, Skiada D, Schnüriger B, Trump M, Lam L, Demetriades D. Prospective evaluation of treatment of open fractures: effect of time to irrigation and Debridement. JAMA Surg 2015;150:332–6. 10.1001/jamasurg.2014.2022 [DOI] [PubMed] [Google Scholar]
- 80. Southwell-Keely JP, Russo RR, March L, Cumming R, Cameron I, Brnabic AJM. Antibiotic prophylaxis in hip fracture surgery: A Metanalysis. Clinical Orthopaedics and Related Research 2004;419:179–84. 10.1097/00003086-200402000-00029 [DOI] [PubMed] [Google Scholar]
- 81. Bryson DJ, Morris DLJ, Shivji FS, Rollins KR, Snape S, Ollivere BJ. Antibiotic prophylaxis in Orthopaedic surgery. The Bone & Joint Journal 2016;98-B:1014–9. 10.1302/0301-620X.98B8.37359 [DOI] [PubMed] [Google Scholar]
- 82. Chang Y, Kennedy SA, Bhandari M, Lopes LC, Bergamaschi C de C, Carolina de Oliveira E Silva M, Bhatnagar N, Mousavi SM, Khurshid S, Petrisor B, et al. Effects of antibiotic prophylaxis in patients with open fracture of the extremities: A systematic review of randomized controlled trials. JBJS Rev 2015;3:e2. 10.2106/JBJS.RVW.N.00088 [DOI] [PubMed] [Google Scholar]
- 83. Lane JC, Mabvuure NT, Hindocha S, Khan W. Current concepts of prophylactic antibiotics in trauma: A review. Open Orthop J 2012;6:511–7. 10.2174/1874325001206010511 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. World Health Organization . Prevention and management of wound infections: Guidance from WHO’s Department of Violence and Injury Prevention and Disability and the Department of Essential Health Technologies, Available: https://www.sctimst.ac.in/Post-flood-Management/General-Health-Care/Care_of_minor_ailments_and_injuries/wound%20infection_WHO.pdf
- 85. Kramer A, Dissemond J, Kim S, Willy C, Mayer D, Papke R, Tuchmann F, Assadian O. Consensus on wound Antisepsis: update 2018. Skin Pharmacol Physiol 2018;31:28–58. 10.1159/000481545 [DOI] [PubMed] [Google Scholar]
- 86. Baum GR, Baum JT, Hayward D, MacKay BJ. Gunshot wounds: ballistics, pathology, and treatment recommendations, with a focus on retained bullets. Orthop Res Rev 2022;14:293–317. 10.2147/ORR.S378278 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Bartlett CS. Clinical update: gunshot wound ballistics. Clin Orthop Relat Res 2003;408:28–57. 10.1097/00003086-200303000-00005 [DOI] [PubMed] [Google Scholar]
- 88. Wolf AW, Benson DR, Shoji H, Hoeprich P, Gilmore A. Autosterilization in low-velocity bullets. J Trauma 1978;18:63. 10.1097/00005373-197801000-00012 [DOI] [PubMed] [Google Scholar]
- 89. Nguyen MP, Como JJ, Golob JF, Reich MS, Vallier HA. Variation in treatment of low energy gunshot injuries - A survey of OTA members. Injury 2018;49:570–4.:S0020-1383(18)30027-5. 10.1016/j.injury.2018.01.027 [DOI] [PubMed] [Google Scholar]
- 90. Nguyen MP, Savakus JC, O’Donnell JA, Prayson NF, Reich MS, Golob JF, McDonald AA, Como JJ, Vallier HA. Infection rates and treatment of low-velocity extremity gunshot injuries. J Orthop Trauma 2017;31:326–9. 10.1097/BOT.0000000000000827 [DOI] [PubMed] [Google Scholar]
- 91. Jabara JT, Gannon NP, Vallier HA, Nguyen MP. Management of civilian low-velocity gunshot injuries to an extremity. J Bone Joint Surg Am 2021;103:1026–37. 10.2106/JBJS.20.01544 [DOI] [PubMed] [Google Scholar]
- 92. Lindsey D. The idolatry of velocity, or lies, damn lies, and ballistics. J Trauma 1980;20:1068–9. 10.1097/00005373-198012000-00012 [DOI] [PubMed] [Google Scholar]
- 93. Hospenthal DR, Murray CK, Andersen RC, Bell RB, Calhoun JH, Cancio LC, Cho JM, Chung KK, Clasper JC, Colyer MH, et al. Guidelines for the prevention of infections associated with combat-related injuries: 2011 update: endorsed by the infectious diseases society of America and the surgical infection society. J Trauma 2011;71:S210–34. 10.1097/TA.0b013e318227ac4b [DOI] [PubMed] [Google Scholar]
- 94. Petersen K, Waterman P. Prophylaxis and treatment of infections associated with penetrating traumatic injury. Expert Rev Anti Infect Ther 2011;9:81–96. 10.1586/eri.10.155 [DOI] [PubMed] [Google Scholar]
- 95. Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nat Rev Dis Primers 2020;6:11. 10.1038/s41572-020-0145-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ 2010;340:c241. 10.1136/bmj.c241 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Barajas-Nava LA, López-Alcalde J, Roqué i Figuls M, Solà I, Bonfill Cosp X. Antibiotic prophylaxis for preventing burn wound infection. Cochrane Database Syst Rev 2013:CD008738. 10.1002/14651858.CD008738.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Ramos G, Cornistein W, Cerino GT, Nacif G. Systemic antimicrobial prophylaxis in burn patients: systematic review. Journal of Hospital Infection 2017;97:105–14. 10.1016/j.jhin.2017.06.015 [DOI] [PubMed] [Google Scholar]
- 99. Csenkey A, Jozsa G, Gede N, Pakai E, Tinusz B, Rumbus Z, Lukacs A, Gyongyi Z, Hamar P, Sepp R, et al. Systemic antibiotic prophylaxis does not affect infectious complications in pediatric burn injury: A meta-analysis. PLoS ONE 2019;14:e0223063. 10.1371/journal.pone.0223063 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Tagami T, Matsui H, Fushimi K, Yasunaga H. Prophylactic antibiotics may improve outcome in patients with severe burns requiring mechanical ventilation: propensity score analysis of a Japanese nationwide database. Clin Infect Dis 2016;62:60–6. 10.1093/cid/civ763 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Mosier MJ, Pham TN. American burn Association practice guidelines for prevention, diagnosis, and treatment of ventilator-associated pneumonia (VAP) in burn patients. J Burn Care Res 2009;30:910–28. 10.1097/BCR.0b013e3181bfb68f [DOI] [PubMed] [Google Scholar]
- 102. Rogers AD, Amaral A, Cartotto R, El Khatib A, Fowler R, Logsetty S, Malic C, Mason S, Nickerson D, Papp A, et al. Choosing wisely in burn care. Burns 2022;48:1097–103. 10.1016/j.burns.2021.09.007 [DOI] [PubMed] [Google Scholar]
- 103. Ravat F, Le-Floch R, Vinsonneau C, Ainaud P, Bertin-Maghit M, Carsin H, Perro G. Antibiotics and the burn patient. Burns 2011;37:16–26. 10.1016/j.burns.2009.10.006 [DOI] [PubMed] [Google Scholar]